Boc-1,3-cis-ACHC-OH

Boc-1,3-cis-ACHC-OH is a Boc-protected, non-proteinogenic amino acid building block featuring a constrained 1,3-cis-aminocyclohexylcarboxylic acid (ACHC) side-chain architecture. Its stereodefined, conformationally restricted framework is commonly leveraged in peptide and peptidomimetic synthesis to influence local geometry and backbone presentation while maintaining a protected amino functionality for controlled coupling. The Boc group enables routine use in protected-amino-acid workflows where N-protection is required to build defined peptide segments.

1. Peptidomimetic Backbone Control

Boc-1,3-cis-ACHC-OH is used by medicinal chemistry and peptide chemistry groups to introduce conformational restriction into peptide-like scaffolds, supporting structure-activity relationship (SAR) studies where local geometry matters. Researchers incorporate this stereodefined ACHC residue into solution-phase or solid-supported peptide assembly workflows to modulate the spatial arrangement of neighboring residues and functional groups, often aiming to improve the interpretability of structure-property trends during lead optimization. The Boc-protected amino functionality supports segment coupling strategies in which the N-terminus is masked until the desired assembly step, helping maintain sequence fidelity in complex analog libraries.

2. Protected Amino Acid Building Block

Boc-1,3-cis-ACHC-OH serves as a specialized protected amino acid building block for custom peptide synthesis and modified peptide development where a non-natural, stereodefined residue is required. Polymer-supported synthesis teams and contract peptide manufacturers use this type of Boc-protected monomer to prepare defined peptide intermediates and fully characterized sequences that include constrained amino acid motifs. In downstream workflows such as analytical characterization (e.g., LC-MS verification of intermediates and final products), the Boc protection pattern supports consistent handling and storage of the monomer prior to coupling, which is particularly valuable when constructing libraries of conformationally constrained analogs.

3. SAR Library Synthesis

Boc-1,3-cis-ACHC-OH is frequently selected for generating stereochemically defined peptide and peptidomimetic analog panels used in SAR campaigns. Medicinal chemistry groups use the 1,3-cis ACHC motif to systematically vary residue identity around the constrained position, enabling comparisons across analogs that differ in side-chain chemistry while keeping the backbone geometry controlled. Because the monomer is already N-protected, it integrates cleanly into protected-residue assembly pipelines used for producing multiple analogs with consistent protection/deprotection logic, supporting efficient iteration between synthesis and analytical evaluation of each library member.

4. Conformationally Constrained Residue

Boc-1,3-cis-ACHC-OH is applied in chemical biology and structural peptide research when a conformationally constrained amino acid is needed to stabilize specific local conformations in peptide constructs. Structural biology-oriented teams incorporate the residue into designed peptide segments to create well-defined shapes for downstream biophysical characterization workflows, such as comparing conformational preferences across analogs. The stereodefined, cis-oriented ACHC framework helps maintain a controlled three-dimensional presentation of the peptide backbone around the incorporation site, which is useful when researchers want to attribute observed structural or functional differences to defined geometric constraints rather than to flexible backbone variation.

1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

2. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

3. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

5. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients